Advertisement
Advertisement
PSTV
PLUS THERAPEUTICS, Inc. Common Stock
3.96
USDSponsored
-0.12
-2.94%
Jun 24, 15:59 UTC -4
Closed
After-Market
3.97
+0.01
+0.25%
PSTV Earnings Reports
Positive Surprise Ratio
PSTV beat 24 of 42 last estimates.
57%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.39M
/-$0.89
Implied change from Q1 26 (Revenue/ EPS)
+34.94%
/-15.24%
Implied change from Q2 25 (Revenue/ EPS)
-0.20%
/-278.00%
PLUS THERAPEUTICS, Inc. Common Stock earnings per share and revenue
On May 15, 2026, PSTV reported earnings of -1.05 USD per share (EPS) for Q1 26, missing the estimate of -0.89 USD, resulting in a -16.98% surprise. Revenue reached 1.03 million, compared to an expected 993.48 thousand, with a 3.47% difference. The market reacted with a +11.24% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.89 USD, with revenue projected to reach 1.39 million USD, implying an decrease of -15.24% EPS, and increase of 34.94% in Revenue from the last quarter.
FAQ
What were PLUS THERAPEUTICS, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, PLUS THERAPEUTICS, Inc. Common Stock reported EPS of -$1.05, missing estimates by -16.98%, and revenue of $1.03M, 3.47% above expectations.
How did the market react to PLUS THERAPEUTICS, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 11.24%, changed from $5.25 before the earnings release to $5.84 the day after.
When is PLUS THERAPEUTICS, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for PLUS THERAPEUTICS, Inc. Common Stock's next earnings report?
Based on 5
analysts, PLUS THERAPEUTICS, Inc. Common Stock is expected to report EPS of -$0.89 and revenue of $1.39M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement